semaglutide and opiates VA Study: Ozempic, Other GLP-1 Drugs May Fight Addiction Across Every Major Substance semaglutide and opioids Live Updates

High Retention: Hers reports lower discontinuation rates compared to traditional programs, largely due to the ease of their digital check-ins

Some surgeons are aware of peptide use among their patients and report faster than expected healing in certain cases

While privacy is respected, samples are monitored closely enough to prevent tampering or substitution

In a systematic review of five studies with the intention of improving LT candidacy, 78% of patients could be listed, and the rate of major and minor complications was 2% and 8%, respectively [47]

Based on Fact.MR analysis, demand for GLP-1 companion products is estimated to grow to around USD 5.2 billion in 2026 and USD 14.4 billion by 2036